Powder: -20°C for 3 years | In solvent: -80°C for 1 year
IOX4 是选择性 PHD2抑制剂,IC50=1.6 nM,在细胞和野生型小鼠中诱导 HIFα表达,可透过血脑屏障。它与 PHD2 特性位点的 2-氧代戊二酸竞争并置换。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
2 mg | ¥ 283 | 现货 | ||
5 mg | ¥ 455 | 现货 | ||
10 mg | ¥ 749 | 现货 | ||
25 mg | ¥ 1,630 | 现货 | ||
50 mg | ¥ 2,430 | 现货 | ||
100 mg | ¥ 3,580 | 现货 | ||
200 mg | ¥ 5,130 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 493 | 现货 |
产品描述 | IOX4 is a potent PHD2 inhibitor (IC50 = 1.6 nM) |
靶点活性 | PHD2:1.6 nM |
体内活性 | IOX4 as a highly potent and selective inhibitor of human PHD2, As shown by studies with mice, IOX4 is useful for in vivo work;?it will then be useful for investigations on the suitability of the PHDs as targets for cerebral diseases such as stroke.?The combined kinetic and biophysical analyses reveal that IOX4 (and IOX2) compete with 2OG for binding to PHD2;?the triazole rings of the inhibitors bind in the pocket occupied by the CH2CH2COOH side chain of 2OG.?The results thus reveal the potential of non-acid containing PHD inhibitors—an important finding given the potential of HIFα upregulation mediated by PHD inhibition in the treatment of stroke, as acids do not often permeate the blood-brain barrier efficiently[1]. |
分子量 | 328.33 |
分子式 | C15H16N6O3 |
CAS No. | 1154097-71-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 83.33 mg/mL (253.80 mM), Sonication is recommended.
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 3.0457 mL | 15.2286 mL | 30.4572 mL | 76.1429 mL |
5 mM | 0.6091 mL | 3.0457 mL | 6.0914 mL | 15.2286 mL | |
10 mM | 0.3046 mL | 1.5229 mL | 3.0457 mL | 7.6143 mL | |
20 mM | 0.1523 mL | 0.7614 mL | 1.5229 mL | 3.8071 mL | |
50 mM | 0.0609 mL | 0.3046 mL | 0.6091 mL | 1.5229 mL | |
100 mM | 0.0305 mL | 0.1523 mL | 0.3046 mL | 0.7614 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
IOX4 1154097-71-8 Chromatin/Epigenetic Metabolism HIF/HIF Prolyl-Hydroxylase HIF-PH HIFs Hypoxia-inducible factors inhibit IOX 4 Inhibitor IOX-4 inhibitor